Cargando…
Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration
BACKGROUND: Pregnant women living with HIV infection (PWLWH) have elevated rates of preterm birth (PTB) in which HIV and cART are implicated. PWLWH also have a high prevalence of adverse vaginal microbiota, which associate with genital tract inflammation. The mechanism underlying PTB in PWLWH is unk...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667959/ https://www.ncbi.nlm.nih.gov/pubmed/34912728 http://dx.doi.org/10.3389/fcimb.2021.750103 |
_version_ | 1784614469123440640 |
---|---|
author | Short, Charlotte-Eve S. Quinlan, Rachael A. Wang, Xuan Preda, Veronica Georgiana Smith, Ann Marchesi, Julian R. Lee, Yooni S. MacIntyre, David A. Bennett, Phillip R. Taylor, Graham P. |
author_facet | Short, Charlotte-Eve S. Quinlan, Rachael A. Wang, Xuan Preda, Veronica Georgiana Smith, Ann Marchesi, Julian R. Lee, Yooni S. MacIntyre, David A. Bennett, Phillip R. Taylor, Graham P. |
author_sort | Short, Charlotte-Eve S. |
collection | PubMed |
description | BACKGROUND: Pregnant women living with HIV infection (PWLWH) have elevated rates of preterm birth (PTB) in which HIV and cART are implicated. PWLWH also have a high prevalence of adverse vaginal microbiota, which associate with genital tract inflammation. The mechanism underlying PTB in PWLWH is unknown. We present the first data in PWLWH on genital-tract matrix-metalloproteinase-9(MMP-9), an important collagenase implicated in labour onset, and tissue inhibitor of metalloproteinases-1(TIMP-1) and explore correlations with local inflammation and vaginal bacteria. MATERIAL AND METHODS: Cervical vaginal fluid (CVF) collected by a soft cup and high vaginal swabs (HVS) were obtained from PWLWH and HIV uninfected pregnant women (HUPW) at three antenatal time points. Maternal characteristics, combination antiretroviral therapy (cART) exposure, and pregnancy outcome were recorded. Concentrations of MMP-9, TIMP-1 and ten cytokines were measured by immunoassays. Vaginal microbiota composition was determined through 16S rRNA amplicon sequencing. MMP-9, TIMP-1 and cytokine concentrations were compared by HIV status, cART, and prematurity and in PWLWH correlations with polymorphonuclear leucocytes, cytokines and bacterial genera were explored. RESULTS: CVF was available for 50 PWLWH (108 samples) and 12 HUPW (20 samples) between gestation weeks 14-38. Thirty-six PWLWH conceived on cART and 14 initiated post-conception. There were five and one PTB outcomes in PWLWH and HUPW respectively. PWLWH had higher mean CVF concentrations of MMP-9 (p<0.001) and TIMP-1 (p=0.035) in the second trimester compared with HUPW with a similar trend in the third trimester. PWLWH also had higher CVF values of cytokines: IL-1β, IL-8, IL-12 and TNF-α in both trimesters compared to HUPW (p ≤ 0.003). In PWLWH, MMP-9 positively correlated with TIMP-1 (r=0.31, p=0.002) and CVF polymorphonuclear leucocytes (r=0.57, p=0.02). Correlations were observed between MMP-9 and three cytokines: IL-1β (r=0.61), IL-8 (r=0.57) and TNF-α (r=0.64), p<0.001, similarly for TIMP-1. Abundance of anaerobic pathobionts correlated with MMP-9: Gardnerella (r=0.44, p<0.001), Atopobium (r=0.33, p=0.005), and Prevotella genera (r=0.39, p<0.001). Conversely proportion of Lactobacillus genera negatively correlated with MMP-9 (rho=-0.46, p<0.001). MMP-9/TIMP-1 ratio increased with gestational age at sampling in PWLWH, but this was no longer significant after adjusting for confounders and no difference by prematurity was observed in this sub-study. CONCLUSIONS: Here we show strong correlations of MMP-9 to genital tract inflammation and sub-optimal bacterial genera in PWLWH indicating the ascending genital tract infection pathway may be a contributory mechanism to the high risk of PTB. |
format | Online Article Text |
id | pubmed-8667959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86679592021-12-14 Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration Short, Charlotte-Eve S. Quinlan, Rachael A. Wang, Xuan Preda, Veronica Georgiana Smith, Ann Marchesi, Julian R. Lee, Yooni S. MacIntyre, David A. Bennett, Phillip R. Taylor, Graham P. Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Pregnant women living with HIV infection (PWLWH) have elevated rates of preterm birth (PTB) in which HIV and cART are implicated. PWLWH also have a high prevalence of adverse vaginal microbiota, which associate with genital tract inflammation. The mechanism underlying PTB in PWLWH is unknown. We present the first data in PWLWH on genital-tract matrix-metalloproteinase-9(MMP-9), an important collagenase implicated in labour onset, and tissue inhibitor of metalloproteinases-1(TIMP-1) and explore correlations with local inflammation and vaginal bacteria. MATERIAL AND METHODS: Cervical vaginal fluid (CVF) collected by a soft cup and high vaginal swabs (HVS) were obtained from PWLWH and HIV uninfected pregnant women (HUPW) at three antenatal time points. Maternal characteristics, combination antiretroviral therapy (cART) exposure, and pregnancy outcome were recorded. Concentrations of MMP-9, TIMP-1 and ten cytokines were measured by immunoassays. Vaginal microbiota composition was determined through 16S rRNA amplicon sequencing. MMP-9, TIMP-1 and cytokine concentrations were compared by HIV status, cART, and prematurity and in PWLWH correlations with polymorphonuclear leucocytes, cytokines and bacterial genera were explored. RESULTS: CVF was available for 50 PWLWH (108 samples) and 12 HUPW (20 samples) between gestation weeks 14-38. Thirty-six PWLWH conceived on cART and 14 initiated post-conception. There were five and one PTB outcomes in PWLWH and HUPW respectively. PWLWH had higher mean CVF concentrations of MMP-9 (p<0.001) and TIMP-1 (p=0.035) in the second trimester compared with HUPW with a similar trend in the third trimester. PWLWH also had higher CVF values of cytokines: IL-1β, IL-8, IL-12 and TNF-α in both trimesters compared to HUPW (p ≤ 0.003). In PWLWH, MMP-9 positively correlated with TIMP-1 (r=0.31, p=0.002) and CVF polymorphonuclear leucocytes (r=0.57, p=0.02). Correlations were observed between MMP-9 and three cytokines: IL-1β (r=0.61), IL-8 (r=0.57) and TNF-α (r=0.64), p<0.001, similarly for TIMP-1. Abundance of anaerobic pathobionts correlated with MMP-9: Gardnerella (r=0.44, p<0.001), Atopobium (r=0.33, p=0.005), and Prevotella genera (r=0.39, p<0.001). Conversely proportion of Lactobacillus genera negatively correlated with MMP-9 (rho=-0.46, p<0.001). MMP-9/TIMP-1 ratio increased with gestational age at sampling in PWLWH, but this was no longer significant after adjusting for confounders and no difference by prematurity was observed in this sub-study. CONCLUSIONS: Here we show strong correlations of MMP-9 to genital tract inflammation and sub-optimal bacterial genera in PWLWH indicating the ascending genital tract infection pathway may be a contributory mechanism to the high risk of PTB. Frontiers Media S.A. 2021-11-29 /pmc/articles/PMC8667959/ /pubmed/34912728 http://dx.doi.org/10.3389/fcimb.2021.750103 Text en Copyright © 2021 Short, Quinlan, Wang, Preda, Smith, Marchesi, Lee, MacIntyre, Bennett and Taylor https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Short, Charlotte-Eve S. Quinlan, Rachael A. Wang, Xuan Preda, Veronica Georgiana Smith, Ann Marchesi, Julian R. Lee, Yooni S. MacIntyre, David A. Bennett, Phillip R. Taylor, Graham P. Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration |
title | Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration |
title_full | Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration |
title_fullStr | Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration |
title_full_unstemmed | Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration |
title_short | Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further Exploration |
title_sort | vaginal microbiota, genital inflammation and extracellular matrix remodelling collagenase: mmp-9 in pregnant women with hiv, a potential preterm birth mechanism warranting further exploration |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667959/ https://www.ncbi.nlm.nih.gov/pubmed/34912728 http://dx.doi.org/10.3389/fcimb.2021.750103 |
work_keys_str_mv | AT shortcharlotteeves vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT quinlanrachaela vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT wangxuan vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT predaveronicageorgiana vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT smithann vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT marchesijulianr vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT leeyoonis vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT macintyredavida vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT bennettphillipr vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration AT taylorgrahamp vaginalmicrobiotagenitalinflammationandextracellularmatrixremodellingcollagenasemmp9inpregnantwomenwithhivapotentialpretermbirthmechanismwarrantingfurtherexploration |